483
Validus Pharmaceuticals, Inc.Validus Pharmaceuticals, Inc. – FDA 483, Nov 13, 2019
Record Details
Validus Pharmaceuticals, Inc. in Parsippany, NJ was inspected by the FDA from November 6-13, 2019, revealing significant deficiencies in postmarketing reporting. The firm failed to timely submit periodic adverse drug experience reports and annual reports for various applications. Additionally, the inspection noted a failure to include copies of published articles with postmarketing 15-day Alert reports based on scientific literature.
- Person
View Company Profile
ID · e8e64a46-c633-4218-997c-0c88d5c8f829
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.